Kidney Function Thresholds Validated by Gold-Standard GFR Testing in Major Study

Chronic kidney disease affects hundreds of millions of people worldwide, and accurate diagnosis depends on correctly measuring how well the kidneys filter waste from the blood — a value called glomerular filtration rate, or GFR. This large retrospective study, published in JAMA and presented at the European Renal Association congress, set out to validate whether the thresholds doctors currently use to diagnose and stage CKD actually hold up against the most accurate GFR measurement method available.

Researchers analyzed data from 6,174 patients and compared outcomes across different GFR levels using directly measured GFR — the reference standard rarely used in routine care due to cost and complexity. They found that a measured GFR of 60 mL/min/1.73 m² was associated with a 21% higher risk of all-cause mortality and nearly three times the risk of kidney failure requiring dialysis or transplant, compared to a GFR of 90. Risk climbed progressively at lower thresholds of 45, 30, and 15.

A key practical finding involved how estimated GFR is calculated in everyday clinical settings. When estimated using creatinine alone, GFR-based risk was underestimated — partly because low muscle mass reduces creatinine levels, artificially inflating the score. Cystatin C alone overestimated risk, since inflammation, obesity, and certain medications raise cystatin C independently of kidney function. Combining both markers produced estimates closely matching directly measured GFR outcomes.

For health-conscious adults, this research reinforces that kidney function is a critical longevity biomarker. Declining GFR is associated with sharply rising mortality risk, making it a meaningful metric to track over time.

Caveats include the study's retrospective design and that measured GFR tests were conducted in specific clinical contexts, which may limit generalizability. The article is a news summary rather than a full primary source review.